Managing Insomnia Using Lucid Dreaming Training: A Pilot Study.

Behavioral sleep medicine  – January 01, 2021

Source: PubMed

Summary

Lucid Dreaming Training for insomnia (LDT-I) shows promise as a non-drug treatment option, with a sample of 48 adults reporting significant improvements. After two weeks of training, participants experienced a large reduction in insomnia severity, with an effect size of 1.17. Additionally, anxiety and depressive symptoms decreased markedly, indicating LDT-I's potential benefits. These findings suggest that LDT-I could be a valuable alternative to traditional Cognitive Behavioral Therapy for Insomnia, warranting further exploration in managing sleep disorders effectively.

Abstract

Objectives/Background: Despite Cognitive Behavioral Therapy for Insomnia (CBT-I) being considered the first-line treatment for insomnia, it is not without its challenges. As such it is worthwhile to consider, and test, alternative or adjuvant management options. Methods/Participants: The aim of the present study was to examine whether Lucid Dreaming Training for insomnia (LDT-I) impacted on insomnia, depressive and anxious symptomology in an open label trial of 48 adults with Insomnia Disorder. Participants completed the Insomnia Severity Index, General Anxiety Disorder-7 and Patient Health Questionnaire at baseline then one month following LDT-I. Training consisted of four modules delivered over a period of two consecutive weeks. Results: The results suggest, albeit preliminarily, that LDT-I may have a place within the non-pharmacological management of insomnia, as there were significant reductions in insomnia severity (t(46) = 8.16,p <.001), anxious symptomology (t(46) = 4.75,p <.001) and depressive symptomology (t(46) = 5.87,p <.001). Further, the effect size in terms of pre-post reductions on ISI scores was large (dz 1.17). Conclusions: Whilst the results are promising, further testing of LDT-I is needed to inform its place amongst the non-pharmacological treatments for insomnia.

Comments

No comments yet.

Log in to comment